Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.
Jiang ZB, Wang WJ, Xu C, Xie YJ, Wang XR, Zhang YZ, Huang JM, Huang M, Xie C, Liu P, Fan XX, Ma YP, Yan PY, Liu L, Yao XJ, Wu QB, Lai-Han Leung E.
Jiang ZB, et al. Among authors: liu l, liu p.
Cancer Lett. 2021 Sep 1;515:36-48. doi: 10.1016/j.canlet.2021.05.019. Epub 2021 May 28.
Cancer Lett. 2021.
PMID: 34052328